Asston Pharmaceu, a company in the Pharmaceuticals industry, reported revenue of ₹15 crore and net profit of ₹3.27 crore for the September 2026 quarter.
Asston Pharmaceu (BSE: APL) closed at ₹162.20 on 20 Nov 2026, up 88.6% over the past year. Its market capitalisation is ₹177 crore and it trades at 47.2 times earnings.
Incorporated in 2019, Asston Pharmaceuticals Ltd is in the business of manufacturing pharmaceutical products.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.